AUD 0.36
(-4.05%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 1.2 Million AUD | -61.57% |
2023 | 3.14 Million AUD | 3.37% |
2022 | 3.04 Million AUD | 0.0% |
2021 | - AUD | 0.0% |
2020 | - AUD | 100.0% |
2019 | -483.27 Thousand AUD | -8.09% |
2018 | -447.08 Thousand AUD | -175.07% |
2017 | -162.53 Thousand AUD | 0.0% |
2016 | - AUD | 0.0% |
2015 | - AUD | 100.0% |
2014 | -11.24 Thousand AUD | 0.0% |
2013 | - AUD | 0.0% |
2012 | - AUD | 100.0% |
2011 | -22.98 Thousand AUD | -266.35% |
2010 | -6273.00 AUD | 70.23% |
2009 | -21.07 Thousand AUD | 0.0% |
2008 | - AUD | 0.0% |
2007 | - AUD | 0.0% |
2006 | - AUD | 0.0% |
2005 | - AUD | 0.0% |
2004 | - AUD | 100.0% |
2003 | -202.00 AUD | 41.45% |
2002 | -345.00 AUD | 0.0% |
2001 | - AUD | 0.0% |
2000 | - AUD | -100.0% |
1999 | 2.64 Million AUD | -31.22% |
1998 | 3.84 Million AUD | -62.96% |
1997 | 10.37 Million AUD | 49.33% |
1996 | 6.94 Million AUD | -57.1% |
1995 | 16.19 Million AUD | 46.1% |
1994 | 11.08 Million AUD | 11.93% |
1993 | 9.9 Million AUD | 59.1% |
1992 | 6.22 Million AUD | -11.25% |
1991 | 7.01 Million AUD | 11.6% |
1990 | 6.28 Million AUD | 23.04% |
1989 | 5.1 Million AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 FY | 1.2 Million AUD | -61.57% |
2024 Q2 | 3.13 Million AUD | 0.0% |
2024 Q4 | 1.2 Million AUD | 0.0% |
2023 Q2 | 3.08 Million AUD | 0.0% |
2023 Q4 | 3.14 Million AUD | 0.0% |
2023 FY | 3.14 Million AUD | 3.37% |
2022 FY | 3.04 Million AUD | 0.0% |
2022 Q4 | 3.04 Million AUD | 0.0% |
2022 Q2 | - AUD | 0.0% |
2021 Q2 | - AUD | 0.0% |
2021 FY | - AUD | 0.0% |
2021 Q4 | - AUD | 0.0% |
2020 Q2 | - AUD | 0.0% |
2020 Q4 | - AUD | 0.0% |
2020 FY | - AUD | 100.0% |
2019 FY | -483.27 Thousand AUD | -8.09% |
2019 Q2 | - AUD | 0.0% |
2019 Q4 | -483.27 Thousand AUD | 0.0% |
2018 Q4 | -426.63 Thousand AUD | 0.0% |
2018 FY | -447.08 Thousand AUD | -175.07% |
2018 Q2 | - AUD | 0.0% |
2017 Q4 | -162.53 Thousand AUD | 0.0% |
2017 FY | -162.53 Thousand AUD | 0.0% |
2017 Q2 | - AUD | 0.0% |
2016 Q2 | - AUD | 0.0% |
2016 Q4 | - AUD | 0.0% |
2016 FY | - AUD | 0.0% |
2015 FY | - AUD | 100.0% |
2015 Q4 | - AUD | 0.0% |
2014 Q4 | - AUD | 0.0% |
2014 FY | -11.24 Thousand AUD | 0.0% |
2013 Q4 | - AUD | 0.0% |
2013 FY | - AUD | 0.0% |
2012 FY | - AUD | 100.0% |
2012 Q4 | - AUD | 0.0% |
2011 FY | -22.98 Thousand AUD | -266.35% |
2011 Q4 | - AUD | 0.0% |
2010 Q4 | - AUD | 0.0% |
2010 FY | -6273.00 AUD | 70.23% |
2009 FY | -21.07 Thousand AUD | 0.0% |
2009 Q4 | - AUD | 0.0% |
2008 FY | - AUD | 0.0% |
2008 Q4 | - AUD | 0.0% |
2007 FY | - AUD | 0.0% |
2007 Q4 | - AUD | 0.0% |
2006 Q4 | - AUD | 0.0% |
2006 FY | - AUD | 0.0% |
2005 FY | - AUD | 0.0% |
2005 Q4 | - AUD | 0.0% |
2004 FY | - AUD | 100.0% |
2004 Q4 | - AUD | 0.0% |
2003 Q4 | - AUD | 0.0% |
2003 FY | -202.00 AUD | 41.45% |
2002 FY | -345.00 AUD | 0.0% |
2002 Q4 | - AUD | 0.0% |
2001 FY | - AUD | 0.0% |
2001 Q4 | - AUD | 0.0% |
2000 FY | - AUD | -100.0% |
2000 Q4 | - AUD | 0.0% |
1999 FY | 2.64 Million AUD | -31.22% |
1999 Q4 | 2.64 Million AUD | 0.0% |
1998 FY | 3.84 Million AUD | -62.96% |
1997 Q4 | 10.37 Million AUD | 0.0% |
1997 FY | 10.37 Million AUD | 49.33% |
1996 FY | 6.94 Million AUD | -57.1% |
1995 FY | 16.19 Million AUD | 46.1% |
1994 FY | 11.08 Million AUD | 11.93% |
1993 FY | 9.9 Million AUD | 59.1% |
1992 FY | 6.22 Million AUD | -11.25% |
1991 FY | 7.01 Million AUD | 11.6% |
1990 FY | 6.28 Million AUD | 23.04% |
1989 FY | 5.1 Million AUD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AdAlta Limited | -1.67 Million AUD | 172.007% |
Acrux Limited | 147 Thousand AUD | -722.703% |
Actinogen Medical Limited | 108.82 Thousand AUD | -1011.261% |
AnteoTech Limited | 221.85 Thousand AUD | -445.114% |
Argenica Therapeutics Limited | - AUD | -Infinity% |
Arovella Therapeutics Limited | - AUD | -Infinity% |
Anatara Lifesciences Ltd | -671.09 Thousand AUD | 280.21% |
Alterity Therapeutics Limited | 1.00 AUD | -120937300.0% |
Amplia Therapeutics Limited | - AUD | -Infinity% |
Avecho Biotechnology Limited | 97.11 Thousand AUD | -1145.275% |
Bio-Gene Technology Limited | - AUD | -Infinity% |
Biome Australia Limited | 1.88 Million AUD | 35.964% |
Biotron Limited | - AUD | -Infinity% |
BTC Health Limited | - AUD | -Infinity% |
Chimeric Therapeutics Limited | - AUD | -Infinity% |
CSL Limited | 8.93 Billion AUD | 99.986% |
Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 88.619% |
Cynata Therapeutics Limited | 108.2 Thousand AUD | -1017.68% |
Dimerix Limited | - AUD | -Infinity% |
EZZ Life Science Holdings Limited | 1.4 Million AUD | 13.69% |
Hexima Limited | - AUD | -Infinity% |
Island Pharmaceuticals Limited | -877.24 Thousand AUD | 237.861% |
Immuron Limited | 1.58 Million AUD | 23.68% |
Immutep Limited | 2.00 AUD | -60468600.0% |
Imugene Limited | - AUD | -Infinity% |
Invex Therapeutics Ltd | -94.98 Thousand AUD | 1373.253% |
Memphasys Limited | 164.76 Thousand AUD | -634.017% |
Nanollose Limited | - AUD | -Infinity% |
Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
Noxopharm Limited | -2.35 Million AUD | 151.261% |
NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
Nyrada Inc. | - AUD | -Infinity% |
Orthocell Limited | 1.17 Million AUD | -2.782% |
PharmAust Limited | - AUD | -Infinity% |
Patrys Limited | - AUD | -Infinity% |
Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
Proteomics International Laboratories Limited | - AUD | -Infinity% |
Prescient Therapeutics Limited | - AUD | -Infinity% |
PYC Therapeutics Limited | -17.99 Million AUD | 106.72% |
Race Oncology Limited | 16.4 Thousand AUD | -7273.782% |
Radiopharm Theranostics Limited | -987.41 Thousand AUD | 222.479% |
Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
Starpharma Holdings Limited | 2.4 Million AUD | 49.777% |
Telix Pharmaceuticals Limited | 17.31 Million AUD | 93.013% |
Tissue Repair Ltd | 214.72 Thousand AUD | -463.228% |
Zelira Therapeutics Limited | 1.25 Million AUD | 3.429% |